Testosterone for Women Online (2026): Who Prescribes It, What It Costs, and What the Evidence Supports

Is testosterone FDA-approved for women?

No. Every testosterone product approved by the FDA in the US is approved for men. When a clinician prescribes testosterone to a woman, it is off-label — either a fraction of a male-dose product or a compounded preparation. Off-label prescribing is legal and common, but it means no FDA-reviewed dosing, safety, or efficacy data exist for the exact product-and-dose a woman receives.

The 2019 Global Consensus Position Statement (Davis et al., published simultaneously across several journals on behalf of a coalition of international medical societies) is the closest thing to a guideline: it recommends that when testosterone is used, the formulation and dose should produce blood concentrations that approximate premenopausal physiological levels — and it cautions against approaches that produce higher-than-physiologic levels.

Is there an FDA-approved testosterone for women?
No. All FDA-approved testosterone products in the US are approved for men. Prescribing for women is off-label, which the 2019 global consensus statement says should be done at doses that keep blood levels in the normal premenopausal range.

What is testosterone actually supported for in women?

Per the 2019 global consensus, the only evidence-based indication is hypoactive sexual desire disorder (HSDD) in postmenopausal women — persistently low sexual desire that causes personal distress, after other contributing causes have been evaluated. The International Society for the Study of Women’s Sexual Health clinical practice guideline reaches the same conclusion.

For the other things testosterone is marketed for — energy, mood, cognition, bone density, muscle mass, general “wellbeing” — the consensus statement reviewed the trials and found the evidence insufficient to support use. That is not the same as proof it does nothing; it means the trials that would justify prescribing for those goals have not shown it. A clinic that promises testosterone will fix fatigue or brain fog is making a claim the evidence does not currently back.

Does testosterone help women with energy or mood?
The 2019 global consensus statement found insufficient evidence to support testosterone for energy, mood, cognition, bone, or muscle in women. The single evidence-based use it identified is low sexual desire with distress (HSDD) in postmenopausal women.

Why won’t many telehealth clinics prescribe it?

Testosterone is listed in Schedule III of the federal Controlled Substances Act (anabolic steroids were scheduled there by Congress in 1990). Federal and state rules for prescribing controlled substances by telehealth are stricter than for ordinary medications and have been in flux for several years, so telehealth programs handle it very differently: some prescribe it with labs and synchronous visits, some restrict it to certain states, and some exclude it entirely.

• MyMenopauseRx states on its own site that “testosterone is a controlled substance in the United States and your specialist is unable to prescribe controlled substances via virtual care.”
• Winona states plainly: “Currently, we do not prescribe testosterone.”
• Elektra Health’s FAQ describes prescribing testosterone only for patients who reside in New York.
• Alloy lists no testosterone product on its solutions page (an absence, not a stated policy — we haven’t seen Alloy state a position either way).
• Inner Balance offers no standalone testosterone; its site describes progesterone “which the body can naturally convert into testosterone” — that is Inner Balance’s framing, not an equivalent to testosterone therapy.

Why do some menopause telehealth clinics not offer testosterone?
Testosterone is a Schedule III controlled substance under the federal Controlled Substances Act, and telehealth prescribing rules for controlled substances are stricter and vary by state. Some programs (Winona, MyMenopauseRx) state on their own sites that they do not prescribe it; others restrict it by state.

Which online clinics prescribe testosterone to women — and at what price?

From RangeYourself’s verified menopause-provider registry, three programs list women’s testosterone on their own sites. Prices below are each program’s own published figures with their pricing model attached — confirm the current number at checkout, since programs change prices without notice:

• Joi Women’s Wellness — testosterone injection $59/month or cream $69/month (per-medication price), on top of a $50/month membership billed quarterly that covers labs and clinician visits (verified July 12, 2026 from Joi’s own site). Note Joi’s own site lists 16 states it cannot ship testosterone to (AL, AR, CT, DE, GA, HI, LA, MN, MO, MS, NC, ND, OK, PA, RI, SC).
• Hone Health — testosterone injections from $28/month or cream from $60/month, priced “+ membership”: Basic membership $25/month or Premium $155/month, plus an upfront biomarker test (Premium: $65 initial test; Basic: $25 initial test plus a $25 onboarding fee) (verified July 12, 2026 from Hone’s own site). Hone’s model is labs-first: a blood test precedes any prescription.
• Defy Medical — offers women’s testosterone via injections, creams/gels, capsules, and pellets as part of individualized BHRT after required blood testing. Defy publishes no fixed price; the only figure on its site is a self-described illustrative, non-guaranteed estimate, so we don’t present one as a price (verified July 12, 2026).

None of these three programs pays RangeYourself a commission — they’re listed because their own sites document a women’s testosterone offering, not because of any relationship.

Where can women get testosterone prescribed online?
From our verified registry: Joi Women’s Wellness (injection $59/mo or cream $69/mo plus $50/mo membership), Hone Health (injections from $28/mo or cream from $60/mo plus $25–$155/mo membership and an upfront lab test), and Defy Medical (individualized, labs required, no published fixed price) — all per each company’s own site, July 2026. Prescribing is off-label and state-dependent.

What about pellets and compounded testosterone?

Because no female-dose product is FDA-approved, women’s testosterone is often compounded — mixed by a pharmacy rather than manufactured as an approved drug. Compounded preparations are legal but are not FDA-reviewed for safety, effectiveness, or consistency. The National Academies’ 2020 review of compounded hormone therapy (NASEM report) found a lack of rigorous evidence for compounded hormones generally.

Implanted pellets deserve particular care: dosing cannot be adjusted after insertion, and clinical guidance (including the ISSWSH guideline) favors formulations that keep blood levels in the physiologic female range and can be titrated or stopped. Ask hard questions before accepting a pellet-first program.

Are testosterone pellets a good option for women?
Guideline-aligned guidance favors formulations that keep blood testosterone in the normal female range and can be adjusted or stopped — pellets can’t be dose-adjusted after insertion. Discuss the trade-offs with a licensed clinician before accepting a pellet-first program.

What should happen before any testosterone prescription?

A guideline-aligned process looks like this: a clinician evaluates what is actually driving your symptoms (sleep, mood, thyroid, iron, other menopause symptoms, medications, relationship factors); if the picture fits HSDD in a postmenopausal woman, testosterone can be discussed as an off-label option; baseline blood levels are checked; a physiologic dose is started; and levels plus response are re-checked on a schedule. A program that skips the evaluation or the monitoring is not following the consensus it will probably cite at you.

If low desire is your main concern, our guide to what actually helps libido in menopause walks through the fuller decision — testosterone is one branch of it, not the default answer.

What should a clinic check before prescribing testosterone to a woman?
An evaluation of what is driving symptoms (sleep, thyroid, iron, mood, medications), confirmation the picture fits HSDD if desire is the concern, baseline blood levels, a physiologic starting dose, and scheduled re-checks. Programs that skip evaluation or monitoring are not following the 2019 consensus guidance.